SEC Comment Letter for Harmony Biosciences Holdings, Inc. (HRMY) (CIK 0001802665) (HRMY) — Sep 13, 2023

Harmony Biosciences Holdings, Inc. (HRMY) (CIK 0001802665)
Date: Sept. 13, 2023 · CIK: 0001802665 · Accession: 0000000000-23-010118

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-39450

Date

September 13, 2023

Author

Sandip Kapadia

Form

UPLOAD

Company

Harmony Biosciences Holdings, Inc. (HRMY) (CIK 0001802665)

Letter

United States securities and exchange commission logo September 13, 2023 Sandip Kapadia Chief Financial Officer Harmony Biosciences Holdings, Inc. 630 W. Germantown Pike, Suite 215 Plymouth Meeting, PA 19462 Re:Harmony Biosciences Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed February 21, 2023 File No. 001-39450 Dear Sandip Kapadia: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
September 13, 2023
Sandip Kapadia
Chief Financial Officer
Harmony Biosciences Holdings, Inc.
630 W. Germantown Pike, Suite 215
Plymouth Meeting, PA 19462
Re:Harmony Biosciences Holdings, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed February 21, 2023
File No. 001-39450
Dear Sandip Kapadia:
            We have completed our review of your filings.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io